The prevalence of neural tube defects in Sétif University Maternity Hospital, Algeria-3 years review (2004-2006)

Pteridines

Volumn 19, Issue 1, 2008, Pages 12-18

  Houcher, Bakhouche ^a   Bourouba, Romyla ^b   Djabi, Farida ^a   Houcher, Zahira ^a  

^a FERHAT ABBAS UNIVERSITY   (Algeria)

^b UNIVERSITY OF BATNA   (Algeria)

Author keywords

Anencephaly; Encephalocele; Neural tube defects; S tif (Algeria); Spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALGERIA; ANENCEPHALUS; ARTICLE; CONSANGUINITY; DELIVERY; ENCEPHALOCELE; FEMALE; FETUS DEATH; GENE FREQUENCY; GENE MUTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNITY WARD; MORBIDITY; MORTALITY; NEURAL TUBE DEFECT; NEWBORN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; SPINA BIFIDA; UNIVERSITY HOSPITAL;

EID: 44949260954     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2008.19.1.12     Document Type: Article

References (77)

1. Botto LD, Moore CA, Khoury MJ, et al. Neural tube defects. N Engl J Med 1999; 341: 1509-19.
2. Jaber L, Karim IA, Jawdat AM, et al. Awareness of folic acid for prevention of neural tube defects in a community with high prevalence of consanguineous marriages. Ann Genet 2004; 47: 69-75.
3. Mortimer EA Jr. The puzzling epidemiology of neural tube defects. Pediatrics 1980; 65: 636-7.
4. Cambell LR, Dayton DH, Sohal GS. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects. Teratology 1986; 34: 171-8.
5. Akar N, Çavdar AO, Arcasoy A. High incidence of neural tube defect in Bursa, Turkey. Pediatric Perinat Epid 1988; 2: 89-92.
6. Iqbal MM. Prevention of neural tube defects by periconceptional use of folic acid. Pediatr Rev 2000; 21: 58-66.
7. Wyszynski D, Nambisan M, Surve T, et al. Antiepileptic Drug Pregnancy Registry. Increased rates of major malformations in offspring exposed to valproate during pregnancy. Neurology 20005; 64: 961-9.
8. Hendricks KA, Nuno OM, Suarez L, et al. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 2001; 12: 630-5.
9. MRC Vitamin Study Research Group. Prevention of neural tube defect: Results of the medical research council vitamin study. Lancet 1991; 338: 131-7.
10. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 1995; 88: 763-6.
11. Czeizel AE, Dudas I. Prevention of the first occurence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
12. Frosst P, Blom MJ, Lios R, et al. Acandidate genetic risk factor for vascular disease : a common mutation in methylenetetrahydrofolate reductase. Nat Gent 1995; 10: 111-3.
13. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-72.
14. Almawi WY, Finan RR, Tamim H, et al. Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 2004; 76: 85-7.
15. Mutchinick OM, Lopez MA, Luna L, et al. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 1999; 68: 461-7.
16. D'Angelo A, Coppola A, Madonna P, et al. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost 2000; 83: 563-70.
17. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
18. Shields DC, Kirke PN, Mills JL, et al. The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects : an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am Hum Genet 1999; 64: 1045-55.
19. Kirke PN, Mills JL, Molloy AM, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 2004; 328: 1535-6.
20. Barber RC, Lammer EJ, Shaw GM, et al. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab 1999; 66: 1-9.
21. Lucock M, Daskalakis I, Briggs D, et al. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c ®t methylenetetrahydrofolate reductase and 2756a®g methionine synthase genotypes. Mol Genet Metab 2000; 70: 27-44.
22. Felix TM, Leistner S, Giugliani R. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 2004; 70: 459-63.
23. The Centers for Disease Control and prevention (CDC). Preventing Neural Tube Birth Defects: A Prevention Model and Resource Guide. Atlanta: CDC, 1998.
24. Windham GC, Edmands LD. Current trends in the incidence of neural tube defects. Pediatrics 1982; 70: 333-7.
25. DeWals P, Trochet C, Pinsonneaut L. Prevalence of neural tube defect in the province of Quebec. Can J Pub Health 1992 ; 90 : 237-9.
26. Murphy PA. Periconceptional supplementation with folic acid: does it prevent neural defects? J Nurse-Midwifery 1992; 37: 25-32.
27. Van Allen MI, Fraser FC, Dallaire L, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Can Med Assoc J 1993; 149: 1239-43.
28. Wilson RD and Van Allen MI. Recommendations on the use of folic acid for the prevention of neural tube defects. J Soc Obstet Gynecol 1993; 15 Suppl: 41-4.
29. Hendricks KA, Simpson JS, Larsen RD. Neural tube defect along the texas-Mexico border, 1993-1995. Am J Epidemiol 1999; 149: 1119-27.
30. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000; 106: 677-83.
31. Koch M, Fuhrmann W. Epidemiology of neural tube defects in Germany . Hum Genet 1984; 68: 97-103.
32. Eurocat Working Group. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis 1980- 86. J Epidemiol Community Health 1991; 45: 52-8.
33. Rankin J, Wyttenbach A, Rubinsztein DC. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Peadiatr Perinat Epidemiol 2000; 14: 104-10.
34. Alembik Y, Dott B, Roth MP, et al. Prevalence of neural tube defects in northeastern France, 1979-1992 impact of prenatal diagnosis. Ann Genet 1995; 38: 49-53.
35. Candito M, Van Obberghen E. Folates, vitamine B12, homocystéine et anomalies du tube neural. Ann Biol Clin (Paris) 2001; 59: 111-2.
36. Buccimazza S, Molteno C, Dunne T, et al. Prevalence of neural tube defects in Cape Town, South Africa. Teratology 1994; 50: 194-9.
37. Tuncbilek E, Boduroglo K, Alikasifoglu M. Neural tube defects in Turkey : prevalence distribution and risk factors. Turk J Pediatr 1999; 41: 299-305.
38. Daoud AS, Al-Kaysi F, El-Shanti H, et al. Neural tube defects in Northern Jordan. Saud Med J 1996; 17: 78-81.
39. Dudin A. Neural tube defects in Palestinians: a hospital based study. Ann Trop Pediatr 1997; 17: 217-22.
40. Samson GR. The incidence and demography of neural tube defects in Abu Dhabi, United Arab Emirates (1992-1999). J Torp Pediatr 2003, 49: 256-7.
41. Khrouf N, Spang R, Podgorna T, et al. Malformations in 10,000 consecutive births in Tunis. Acta Paediatr Scand 1986; 75: 534-9.
42. Golalipour MJ, Mobasheri E, Vakili MA, et al. Epidemiology of neural tube defects in Northern Iran, 1998-2003. Eastern Mediterr Health J 2007, 3: 560-6.
43. Xiao KZ, Zhang ZY, Su YM, et al. Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monotoring Program. Int J Epidemiol 1990; 19: 978-82.
44. Dai L, Zhu J, Zhou G, et al. Dynamic monitoring of neural tube defects in China during 1996 to 2000. Chinese J Prevent Med 2002; 36: 402-5.
45. Li Z, Ren A, Zhang L, et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi province, China. Birth Defects Res A Clin Mol Teratol 2006; 76: 237-40.
46. Samaha I, Rady M, Nabhan A, et al. The prevalence of congenital malformations at birth in Ain Shams University Maternity Hospital Cairo, Egypt. J Egypt Public Health Assoc 1995; 70: 595-608.
47. Harris JA, James L. State-by-state cost of birth defects-1992. Teratology 1997; 56: 11-6.
48. Soumaya SG, Aida M, Sami M, et al. Encephalocele : 26 retrospective cases at the maternal and neonatal center of La Rabta, Tunis. Tunis Med 2001, 79: 51-3
49. Wasant P, Sathienkijkanchai A. Neural tube defects at Siriraj hospital, Bangkok, Thailand-10 years review (1990-1999). J Med Assoc Thai 2005, 88: S92-S98.
50. McDonnell RJ, Johnson Z, Delaney V, et al. East Ireland 1980-1994 : epidemiology of neural tube defects. J Epidemiol Community Health 1999; 53: 782-8.
51. Williamson RA, Schauberger CW, Varner MW, et al. Heterogeneity of prenatal onset hydrocephalus: Management and counseling implications. Am J Med Genet 1984; 17: 497-504.
52. Rintoul NE, Sutton LN, Hubbard AM, et al. A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 2002; 109: 409-13.
53. Cohen T, Stern E, Rosenman A. Sub risk of neural tube defect. Is prenatal diagnosis indicated in pregnancies following the birth of a hydrocephalic child? J Med Genet 1979; 16: 14-6.
54. Lary JM, Paulozzi LJ. Sex differences in the prevalence of human birth defects: a population-based study. Teratology 2001; 64: 237-51.
55. Rittler M, Lopez CJ, Castilla EE. Sex ratio and associated risk factors for 50 congenital anomaly types: clues for causal heterogeneity. Birth Defects Res A Clin Mol Teratol 2004; 70: 13-9.
56. Office for Population Censuses and Surveys. Congenital malformation statistics: notifications 1981-85. London: HMSO, 1988.
57. Houcher B, Candito M, Poitier de Courcy G, et al. Nutritional assesment of folate status in a population of Sétif, Algeria. Pteridines 2003; 14: 138-142.
58. Bates CJ, Prentice AM , Paul AA. Seasonal variations in vitamins A, C, riboflavin and folate intake and status of pregnant and lactating women in a rural Gambian community: some possible implications. Eur J Clin Nutr 1994; 48: 660-8.
59. Clarke R, Woodhouse P, Ulvik A, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 1998; 44: 102-7.
60. Murshid WR. Spina bifida in Saudi Arabia : is consanguinity among the parents a risk factor? Pediatric neurosurgery 2000; 32: 10-2.
61. Khoury SA, Massad D. Consanguineous marriage in Jordan. Am J Med Genet 1992; 43: 769-75.
62. Teebi AS. Autosomal recessive disorders among Arabs: an overview from Kuwait. J Med Genet 1994; 31: 224-33.
63. Benallegue A, Kedji F. Consanguinité et santé publique: Une étude algérienne Arch Fr Pédiatr 1984; 41: 435-40.
64. Zaoui S, Biemont C. Frequency of consanguineous unions in the Tlemcen area (West Algeria). Santé 2002; 12: 289-95.
65. Hamamy H, Jamhawi L, Al-Darawsheh J, et al. Consanguineous marriages in Jordan: Why is the rate changing with time? Clin Genet 2005; 67: 511-6.
66. Zlotogora J. Genetic disorders among Palestinian Arabs: 1. Effects of consanguinity. Am J Med Genet 1997; 68: 472-5.
67. Rajab A, Vaishnav A, Freeman NV, et al. Neural tube defects and congenital hydrocephalus in the Sultanate of Oman. J Trop Pediatr 1998; 44: 300-3.
68. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980, 1: 339-40.
69. Morin VI, Mondor M, Willson RD. Knowledge on periconceptional use of folic acid in women of Brithsh Columbia. Fetal Diagn. ther 2001; 16: 111-5.
70. Frey L and Hauser WA. Epidemiology of neural tube defects. Epilepsia 2003; 44 (Suppl. 3): 4-13.
71. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999; 341: 1485-90.
72. Ray JG, Meier C, Vermeulen MJ, et al. Association of neural tube defects and folic acid food fortification in Canada. The Lancet 2002; 360: 2047-8.
73. Candito M, Houcher B, Boisson C, et al. Neural tube defects and vitamin B12 : a report of three cases. Ann Biol Clin (Paris) 2004; 62: 235-238.
74. Williams LJ, Rasmussen SA, Flores A, et al. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005; 116: 580-6.
75. Bourouba R, Houcher B, Djabi F, et al. The prevalence of methylenetetrahydrofolate reductase C677T, factor V Leiden (1691G-A) and prothrombin (20210G-A) mutations in healthy populations in Sétif region, Algeria (to be published)
76. Grandone E, Corrao AM, Colaizzo D, et al. Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat Diagn 2006; 26: 1-5.
77. Akar N, Akar E, Araç B, et al. Does SLC30A4 (ZNT4) gene exon 5 915 T-C alteration play a role in neural tube defects? Trace Elem Electr 2006; 23: 266-9.